Satellite Biosciences, Inc. — Form D
Satellite Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-11. The offering totals $100.0M, of which $82.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-11
- Form: D
- Accession: 0001832180-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $82.5M
- Remaining: $17.5M
- Investors: 10
- Date of first sale: 2022-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-436997
Issuer
- Name: Satellite Biosciences, Inc.
- CIK: 0001832180
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 6179329047
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Christopher Chen | Director | Cambridge, MA |
| David Lennon | Director | Cambridge, MA |
| Eileen McGuire | Director | BOSTON, MA |
| YAIR SCHINDEL | Director | Ra'anana, L3 |
| Ling Wong | Director | Cambridge, MA |
| William Young | Director | Austin, TX |
| Laura Lande-Diner | Executive Officer | REDWOOD CITY, CA |
| David Lennon | Executive Officer | Cambridge, MA |
| Diane Marcou | Executive Officer | Cambridge, MA |
| Sangeeta Bhatia | Promoter | Cambridge, MA |
| Christopher Chen | Promoter | Cambridge, MA |
| Ellie McGuire | Director | NEW YORK, NY |
| Sujata Bhatia | Director | Cambridge, MA |
| Thomas Lowery | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More